NEW YORK, March 22, 2019 /PRNewswire/ --
Amarin Corporation plc (AMRN)
Lifshitz & Miller announces investigation into possible securities laws violations in connection with
allegations that Amarin administered an active agent to their placebo group during the Vascepa trial, which consequently
exaggerated the efficacy of Vascepa.
If you are AMRN investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
Clementia Pharmaceuticals Inc. (CMTA)
Lifshitz & Miller announces investigation into possible breaches of fiduciary duties in connection with
the sale of CMTA to Ipsen for $25 per share.
If you are a CMTA investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
CVS Health Corporation (CVS)
Lifshitz & Miller announces investigation into possible breaches of fiduciary duties in connection
with CVS' lowered stock value due to poor results from the company's 2015 acquisition of Omnicare, Inc.
If you are a CVS investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
Diplomat Pharmacy, Inc. (DPLO)
Lifshitz & Miller announces an investigation into possible securities laws violations in connection
with DPLO's announcement that it was delaying its financial results and will need to record a non-cash impairment charge.
If you are a DPLO investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
GTx, Inc. (GTXI)
Lifshitz & Miller announces investigation into possible breach of fiduciary duties in connection with
the merger of GTx with Oncternal Therapeutics.
If you are a GTx investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail
at info@jlclasslaw.com.
Mutli-Color Corporation (LABL)
Lifshitz & Miller announces investigation into possible breach of fiduciary duties in connection with
the sale of LABL to Platinum Equity LLC for $50.00 per share.
If you are a LABL investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
Osiris Therapeutics, Inc. (OSIR)
Lifshitz & Miller announces investigation into possible securities laws violations in connection with
the sale of OSIR to Smith & Nephew for $19.00 per share.
If you are a OSIR investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
The Kraft Heinz Company (KHC)
Lifshitz & Miller announces investigation into possible securities laws violations in connection
with a subpoena KHC received from the SEC regarding its accounting practices.
If you are a KHC investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
ATTORNEY ADVERTISING.© 2019 Lifshitz & Miller LLP. The law firm responsible for this
advertisement is Lifshitz & Miller LLP, 821 Franklin Avenue, Suite 209, Garden City, New
York 11530, Tel: (516)493-9780. Prior results do not guarantee or predict a similar outcome with respect to any
future matter.
Contact:
Joshua M. Lifshitz, Esq.
Lifshitz & Miller LLP
Phone: 516-493-9780
Facsimile: 516-280-7376
Email: info@jlclasslaw.com
View original content:http://www.prnewswire.com/news-releases/lifshitz--miller-llp-announces-investigation-of-amarin-corporation-plc-clementia-pharmaceuticals-inc-cvs-health-corporation-diplomat-pharmacy-inc-gtx-inc-multi-color-corporation-osiris-therapeutics-inc-and-the-kraft-300817176.html
SOURCE Lifshitz & Miller Law Firm